Jazz Pharmaceuticals Plc (JAZZ)

0.05 0.04
NASDAQ : Health Technology
Prev Close 130.82
Open 131.29
Day Low/High 130.65 / 131.75
52 Wk Low/High 113.52 / 174.00
Volume 74.05K
Avg Volume 456.50K
Exchange NASDAQ
Shares Outstanding 56.62M
Market Cap 7.58B
EPS 7.50
P/E Ratio 12.11
Div & Yield N.A. (N.A)

Jazz numbers raised at UBS

Jazz numbers raised at UBS

Earnings Roundup

Here is my compilation of last night's profit reports. 24 beats: W&T Offshore (WTI) Oasis Petroleum (OAS) Marathon Oil (MRO) Huntington Ingalls Industries (HII) Cognizant Technology Solutions (CTSH) Disney (DIS) Electronic Arts (EA) Regency Centers ...

A Health Care Trio in Rally Mode

Jazz Pharmaceuticals, Parexel and HCA have made recent upside moves in heavy volume.

Healthy Retracements Refuel Bull Run

Healthy Retracements Refuel Bull Run

Brittany Umar and Scott Redler, chief strategic officer at T3Live.com, reveal how to trade stocks ahead of earnings season: retail, banks, tech.

Two Biopharmaceutical Growth Stars

Jazz and Questcor offer investors reasonable valuations in this area.

JAZZ in Thirds

While the stock is still drifting lower, it is doing so on lighter volume, so I'll cover one-third of my short. Jazz Pharmaceuticals (JAZZ) continues to trade poorly after forming a head-and-shoulders pattern. I wrote about this in my April 13 colum...

JAZZ Plays a Sour Note

JAZZ Plays a Sour Note

I wouldn't be surprised to see JAZZ lose another 10% from here before finding support.

Jazz Pharma numbers raised at Jefferies

Trading in an Extended Market

I'm flipping into strength and continuing to look for pockets of momentum.

Sticking With Long Plays

I'm not seeing any real weakness yet to justify a short.

Keep Digging for Opportunities

The dip-buying is good but we need to see stronger momentum and better leadership.

A Gap Up and Fade

The action is strong, but the market isn't gaining additional traction.

Trades Can Still Work When Things Stink

There isn't necessarily any correlation between the way stocks trade and the feeling about the economy.

Biotech Has Momentum

Takeover news has the sector buzzing this morning.

Searching for a Pulse

It's not that the market action is bad, it just isn't lively enough to support aggressive action.

The Day Ahead: Futures Point Higher

Anticipation of a positive jobs report shows Wall Street edging higher in the early going.

Our September Report Card

Our September Report Card

We had great trades on the euro and the SPX, but we had some bad ones in FXF, SI and JAZZ.

Biotech Is Booming

Biotech Is Booming

Despite the solid performance so far this year, there's still time to get on board and ride the profit train.

S&P 500 on the Edge of a Breakout

S&P 500 on the Edge of a Breakout

If the market likes what it hears from the Fed, we could close above the important 1,219 level.

Chasing Big-Caps

Anticipation of the Fed announcement is likely to keep bids in place and keep the selling from gaining momentum.

Jazz Pharmaceuticals Is Swinging

Jazz Pharmaceuticals Is Swinging

Its chart shows that buyers are becoming more aggressive than sellers.